Xianglin Hu

732 total citations
20 papers, 303 citations indexed

About

Xianglin Hu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Xianglin Hu has authored 20 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Immunology. Recurrent topics in Xianglin Hu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). Xianglin Hu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). Xianglin Hu collaborates with scholars based in China, United States and India. Xianglin Hu's co-authors include Yangbai Sun, Dong Yang, Yun Feng, Yuanlin Song, Lu Wang, Jing Xu, Chaomin Wu, Yue Shen, Chunling Du and Wangjun Yan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Signal Transduction and Targeted Therapy.

In The Last Decade

Xianglin Hu

19 papers receiving 300 citations

Peers

Xianglin Hu
Ivette Buendía-Roldán Mexico
Chenli Chang China
Valentina Da Prat Italy
Ángela Quintana Spain
Zihan Xia China
Yunfeng Zhang China
José Manuel Vagace Spain
Jeong Eun Song South Korea
Kimitaka Akaike Japan
Oskar Eriksson Sweden
Ivette Buendía-Roldán Mexico
Xianglin Hu
Citations per year, relative to Xianglin Hu Xianglin Hu (= 1×) peers Ivette Buendía-Roldán

Countries citing papers authored by Xianglin Hu

Since Specialization
Citations

This map shows the geographic impact of Xianglin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Hu more than expected).

Fields of papers citing papers by Xianglin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Hu. The network helps show where Xianglin Hu may publish in the future.

Co-authorship network of co-authors of Xianglin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglin Hu. A scholar is included among the top collaborators of Xianglin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglin Hu. Xianglin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Jialin, Wenjie Liu, Shiyang Zhong, et al.. (2025). Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity. Cancer Immunology Immunotherapy. 74(6). 183–183. 1 indexed citations
2.
Li, Hui, Wenchao Li, & Xianglin Hu. (2025). Association between vitamin C, D, and K intake and inflammatory bowel disease risk: findings from 2009 to 2010 NHANES. BMC Gastroenterology. 25(1). 177–177.
3.
Hu, Xianglin, Hongrun Wu, Yani Kang, et al.. (2024). Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment. Clinical & Experimental Metastasis. 42(1). 8–8. 3 indexed citations
4.
Hu, Xianglin, Sean M. Barber, Weiluo Cai, et al.. (2023). Implant failure and revision strategies after total spondylectomy for spinal tumors. Journal of bone oncology. 42. 100497–100497. 2 indexed citations
5.
Wang, Xiaocen, et al.. (2022). Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD. SHILAP Revista de lepidopterología. 5 indexed citations
6.
Hu, Xianglin, et al.. (2022). Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results. Frontiers in Cellular and Infection Microbiology. 12. 971933–971933. 4 indexed citations
7.
8.
Hu, Xianglin, et al.. (2021). Clinical characteristics of discharged COVID‑19 patients with reappeared positive nucleic acid test. 42(6). 867–871. 1 indexed citations
9.
Hu, Xianglin, Zhengwang Sun, Fengfeng Li, et al.. (2021). Burn-induced heterotopic ossification from incidence to therapy: key signaling pathways underlying ectopic bone formation. Cellular & Molecular Biology Letters. 26(1). 34–34. 26 indexed citations
10.
11.
Xu, Jing, Dong Yang, Yue Shen, et al.. (2020). COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduction and Targeted Therapy. 5(1). 256–256. 139 indexed citations
12.
Wu, Xu, Xianglin Hu, Weiping Hu, Guiling Xiang, & Shanqun Li. (2020). Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: a systematic review and meta-analysis. Bioscience Reports. 40(5). 8 indexed citations
13.
Wang, Xiaocen, Xiaojing An, Xun Wang, et al.. (2019). Peroxiredoxin 6 knockout aggravates cecal ligation and puncture-induced acute lung injury. International Immunopharmacology. 68. 252–258. 16 indexed citations
14.
Xu, Binghe, Q. Zhang, Tao Sun, et al.. (2019). Efficacy and safety of first China-manufactured trastuzumab biosimilar HLX02 for metastatic breast cancer: A phase III trial. Annals of Oncology. 30. v106–v107. 2 indexed citations
15.
16.
Shen, Lin, Linhua Zhang, Xianglin Hu, et al.. (2018). Atezolizumab monotherapy in Chinese patients with locally advanced or metastatic solid tumours. Annals of Oncology. 29. ix49–ix49. 9 indexed citations
17.
18.
Hu, Xianglin, Lin Xu, Xiaocen Wang, et al.. (2018). Prevalence of and risk factors for presenting initial respiratory symptoms in patients undergoing surgery for lung cancer. Journal of Cancer. 9(19). 3515–3521. 5 indexed citations
19.
20.
Li, J., et al.. (2008). Randomized Phase II Trial on Mitomycin-C/Cisplatin ± KLT in Heavily Pretreated Advanced Breast Cancer. The American Journal of Chinese Medicine. 36(4). 665–674. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivette Buendía-Roldán Breakdown of academic impact, for papers by Chenli Chang Breakdown of academic impact, for papers by Valentina Da Prat Breakdown of academic impact, for papers by Ángela Quintana Breakdown of academic impact, for papers by Zihan Xia Breakdown of academic impact, for papers by Yunfeng Zhang Breakdown of academic impact, for papers by José Manuel Vagace Breakdown of academic impact, for papers by Jeong Eun Song Breakdown of academic impact, for papers by Kimitaka Akaike Breakdown of academic impact, for papers by Oskar Eriksson
Rankless by CCL
2026